Regulation

Healthcare Prior Authorization Automation – Review
Technology Healthcare Prior Authorization Automation – Review

The administrative architecture of modern medicine has reached a critical failure point where the velocity of insurance-side decision-making far outpaces the manual capabilities of clinical providers. For decades, the fax machine served as the primary heartbeat of the medical authorization process,

Can Galleri Redefine Early Cancer Detection Standards?
Care Can Galleri Redefine Early Cancer Detection Standards?

The ability to identify a lethal tumor through a single vial of blood has long been considered the holy grail of oncology, moving the medical community closer to a future where reactive treatment is replaced by proactive prevention. At the center of this movement is Grail’s Galleri test, a m

Telix Seeks European Approval for Glioma Imaging Agent
Technology Telix Seeks European Approval for Glioma Imaging Agent

Navigating the intricate landscape of neuro-oncology requires diagnostic tools that can distinguish between treatment-related tissue changes and the actual recurrence of aggressive malignant cells. Telix Pharmaceuticals has addressed this clinical necessity by submitting a formal application for

Should States Ban Wage Garnishment for Medical Debt?
Business Should States Ban Wage Garnishment for Medical Debt?

Expert Faisal Zain brings a wealth of knowledge to the intersection of medical innovation and the complex financial systems that govern patient care. With years of experience in the medical device industry and a deep understanding of the administrative hurdles within healthcare, he has become a

Can Wyoming Turn a Grant Into a Forever Fund?
Business Can Wyoming Turn a Grant Into a Forever Fund?

In the vast, sparsely populated landscapes of Wyoming, state officials have unveiled a financial strategy so audacious it borders on alchemy: a plan to transform a temporary federal grant into a permanent, self-sustaining lifeline for its struggling rural healthcare system. The proposal, centered

Psilocybin Drug Passes Major Trial for Depression
Public Policy Psilocybin Drug Passes Major Trial for Depression

A significant advancement in psychiatric medicine has emerged from the clinical pipeline, as a novel psilocybin-based compound demonstrated conclusive success in a pivotal late-stage trial for treatment-resistant depression. This development signals a potential paradigm shift, moving

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later